Interest of quantitative pp65 cytomegalovirus antigenemia assay for human immunodeficiency virus-positive patients.
Ranger-Rogez
S
S
Couty
J P
JP
Nicot
T
T
Denis
F
F
Rogez
J P
JP
Riche
A
A
Weinbreck
P
P
D017088:AIDS-Related Opportunistic Infections / Q000175:diagnosis* / Q000821:virology; D000328:Adult; D000368:Aged; D000956:Antigens, Viral / Q000097:blood*; D003587:Cytomegalovirus / Q000276:immunology / Q000302:isolation & purification*; D003586:Cytomegalovirus Infections / Q000150:complications* / Q000175:diagnosis* / Q000821:virology; D017726:Cytomegalovirus Retinitis / Q000150:complications / Q000175:diagnosis / Q000821:virology; D005260:Female; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D010750:Phosphoproteins / Q000097:blood* / Q000276:immunology; D011446:Prospective Studies; D014763:Viral Matrix Proteins / Q000097:blood* / Q000276:immunology
D000956:Antigens, Viral; D010750:Phosphoproteins; D014763:Viral Matrix Proteins; C065418:cytomegalovirus matrix protein 65kDa